Research interests focus on impact of innate cells (and cancer cells) on various aspects of anti-cancer T cell responses.
Andersen, R. S., P. Kvistborg, T. M. Frosig, N. W. Pedersen, R. Lyngaa, A. H. Bakker, C. J. Shu, P. thor Straten, T. N. Schumacher, and S. R. Hadrup. 2012. Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers. Nat. Protoc. 7: 891-902.
Becker, J. C., P. thor Straten, and M. H. Andersen. 2013. Self-reactive T cells: suppressing the suppressors. Cancer Immunol. Immunother. 63: 313-319.
Lyngaa, R., N. W. Pedersen, D. Schrama, C. A. Thrue, D. Ibrani, O. Met, P. thor Straten, P. Nghiem, J. C. Becker, and S. R. Hadrup. 2014. T-cell responses to oncogenic Merkel cell polyomavirus proteins distinguish Merkel cell carcinoma patients from healthy donors. Clin. Cancer Res. 20: 1768-1778.
Gang, A. O., T. M. Frosig, M. K. Brimnes, R. Lyngaa, M. B. Treppendahl, K. Gronbaek, I. H. Dufva, P. thor Straten, and S. R. Hadrup. 2014. 5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies. Blood Cancer J. 4:e197. doi: 10.1038/bcj.2014.14.:e197.
Institute for Clinical Medicine
Herlev Hospital
University of Copenhagen
Herlev Ringvej 75
2730 Herlev
2200 Copenhagen
Denmark
Tel.: +45 38 68 38 68
per.thor.straten@regionh.dk